Evidence map›Paper›PMID 41639920›Full record

ArticleArchives of public health = Archives belges de sante publique2026

Changes in premature mortality burden due to lung cancer attributable to tobacco exposure in rural southwest China: three repeated cross-sectional studies from 2013 to 2025.

Guo-Hui Li, Qing-Rou Bao, Rui-Min Shi, Fan Gu, Guo-Yu Ma, Allison Rabkin Golden, Le Cai

Abstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guo-Hui LiNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, 1168 Yu Hua Street Chun Rong Road, Cheng Gong New City, Kunming, 650500, China.
Qing-Rou BaoNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, 1168 Yu Hua Street Chun Rong Road, Cheng Gong New City, Kunming, 650500, China.
Rui-Min ShiNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, 1168 Yu Hua Street Chun Rong Road, Cheng Gong New City, Kunming, 650500, China.
Fan GuNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, 1168 Yu Hua Street Chun Rong Road, Cheng Gong New City, Kunming, 650500, China.
Guo-Yu MaThe Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Allison Rabkin GoldenNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, 1168 Yu Hua Street Chun Rong Road, Cheng Gong New City, Kunming, 650500, China.
Le CaiNHC Key Laboratory of Drug Addiction Medicine, Kunming Medical University, 1168 Yu Hua Street Chun Rong Road, Cheng Gong New City, Kunming, 650500, China. caile002@hotmail.com.

Funding

Graduate Education Innovation Fund of Kunming Medical University 2025B020the First-Class Discipline Team of Kunming Medical University 2024XKTDTS16the key research and development program of the Yunnan Provincial Science and Technology Department 202403AC100015-03the National Natural Science Fund of China 72564027
6 · The paper itself

Abstract

backgroundTobacco exposure remains the leading preventable cause of lung cancer. However, long-term trends in tobacco-related lung cancer premature mortality have been insufficiently studied in rural China. This study aimed to determine premature mortality burden due to lung cancer attributable to smoking and secondhand smoke (SHS) exposure in rural southwest China from 2013 to 2025.

methodsYears of life lost (YLL) per 1,000 and mortality rate per 100,000 due to lung cancer were calculated from medical death certificates, while smoking and SHS exposure data were collected from three waves of cross-sectional interviews conducted in 2013, 2019, and 2025 among individuals aged ≥ 35 years in rural China. The population attributable fraction (PAF) was used to derive mortality and YLL due to lung cancer attributable to tobacco exposure.

resultsFrom 2013 to 2025, prevalence of smoking increased in men (75.56% vs. 81.12%, P < 0.01) but declined in women (2.34% vs. 1.40%, P < 0.01), while prevalence of exposure to SHS decreased significantly both in men (34.66% vs. 20.57%, P < 0.01) and women (44.12% vs. 28.24%, P < 0.01). The mortality and YLL rate of lung cancer rose significantly from 11.67 to 38.34 per 100,000 population and from 1.77 to 4.92 per 1,000 population, respectively. These increasing rates were also observed in both sexes, with the largest relative increase occurring among men. The age-standardized mortality and YLL rate of lung cancer attributable to both smoking and exposure to SHS increased consistently in men and women over the study period. Further, smoking contributed much more to mortality and YLL due to lung cancer than exposure to SHS in men, while the difference in contributions among women was less pronounced.

conclusionsThe premature mortality burden due to lung cancer attributable to smoking and SHS exposure has increased substantially in rural southwest China over the twelve-year study period. Future lung cancer prevention and management efforts should prioritize reducing smoking in men as well as strengthening protections against SHS exposure in women and other non-smoking populations.

Indexed as

ChinaLung cancerPremature mortality burdenSecondhand smoke exposureSmokingTemporal trend

Identifiers

PMID41639920
PMCPMC12973736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.